Trials, therapies, and evidence that changes care.
medRxiv
Verdict: NotableBackground Malaria and HIV remain major causes of illness in sub-Saharan Africa, accounting for 94% of the global malaria burden and over two-thirds of the global HIV burden.
Background Orforglipron is an oral, non-peptide GLP-1 receptor agonist.
Social media language and digital lifestyle behaviours are promoted as scalable signals of population mental health, but predictive models are often evaluated in ways that overstate accuracy.
Safiglipron is an oral small-molecule glucagon-like peptide-1 (GLP-1) receptor agonist administered without fasting or dietary restrictions.
Background Pulsed-field ablation (PFA) has recently been approved in the USA as a new method for treating atrial fibrillation (AF).
Background Hypofractionated radiotherapy is an established alternative to conventional fractionation for breast cancer, but long-term evidence after mastectomy with regional nodal ....